Clinical Signs of Acyclovir Sensitivity
Acyclovir sensitivity, often referring to hypersensitivity or allergic reactions, appears as skin rashes, hives (urticaria), itching, or redness at the application site for topical forms. Systemic reactions from oral or IV use include swelling (angioedema), fever, or breathing difficulties in severe cases. These mimic typical drug allergies and usually emerge within hours to days of starting treatment.[1][2]
Diagnostic Tests for Confirmation
Skin prick or intradermal testing identifies IgE-mediated allergy: dilute acyclovir solution is applied or injected, checking for wheal-and-flare response after 15-20 minutes. Patch testing detects delayed hypersensitivity, with readings at 48 and 96 hours. Oral challenge under medical supervision confirms if tests are negative but suspicion persists. Blood tests for specific IgE are unreliable for acyclovir.[1][3]
Differentiating from Viral Resistance
Sensitivity (allergy) differs from acyclovir resistance, where herpes simplex virus (HSV) or varicella-zoster virus (VZV) mutates, reducing drug efficacy. Resistance shows via failed treatment despite adequate dosing, confirmed by plaque reduction assays or genotypic testing for thymidine kinase mutations. Clinical clues include recurrent lesions in immunocompromised patients.[2][4]
Risk Factors and Who Gets Tested
At-risk groups include those with prior antiviral allergies, atopic history, or multiple herpes outbreaks. Test if symptoms recur with re-exposure. Immunocompromised patients (e.g., HIV, transplant) face higher resistance risk, not sensitivity, prompting viral genotyping over allergy tests.[2][5]
Management After Identification
Stop acyclovir immediately. Switch to alternatives like valacyclovir (if not cross-reactive), famciclovir, or foscarnet for resistant cases. Antihistamines or corticosteroids treat mild reactions; epinephrine handles anaphylaxis. Desensitization protocols exist for unavoidable use.[1][3]
[1]: UpToDate, "Acyclovir: Drug Information" (uptodate.com/contents/acyclovir-drug-information).
[2]: CDC, "Herpes Simplex Virus" (cdc.gov/std/herpes).
[3]: Journal of Allergy and Clinical Immunology, "Hypersensitivity to Acyclovir" (jacionline.org/article/S0091-6749(18)30012-5/fulltext).
[4]: Clinical Infectious Diseases, "Antiviral Resistance in HSV" (academic.oup.com/cid/article/70/Supplement_2/S134/5828240).
[5]: NIH, "Antiviral Drugs for Herpesviruses" (ncbi.nlm.nih.gov/books/NBK47447).